Clinical Trial Update: Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma [NA]

View source ↗

Summary

A clinical trial is evaluating adjuvant stereotactic body radiation therapy after trans-arterial chemoembolization for unresectable hepatocellular carcinoma; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: RWTH Aachen University | Conditions: Hepatocellular Carcinoma Non-resectable | NA | Status: NOT_YET_RECRUITING